Skip to main content
. 2020 Nov 23;20:1130. doi: 10.1186/s12885-020-07580-z

Fig. 4.

Fig. 4

Correlation of recurrence-free survival with EpCAM classification groups. a: Kaplan Meier analysis showing significantly reduced recurrence-free survival of patients with HCC with homogeneous EpCAM expression, when compared to heterogeneous EpCAM-expressing and EpCAM-negative HCC. b. Cox-Regression model including hazard ratios showing higher risk of reduced recurrence-free survival of HCC with homogeneous EpCAM expression